SkinBioTherapeutics – full-year results, still a “transformational” progress Buy?
By Tom Winnifrith & Steve Moore | Saturday 4 December 2021
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
SkinBioTherapeutics(SBTX) has announced results for its year ended 30th June 2021 emphasising “transformational” progress. So what is this?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.